Leissner K H, Gustavsson B
J Urol. 1982 Oct;128(4):697-9. doi: 10.1016/s0022-5347(17)53140-7.
The pharmacokinetics of 5-fluouracil were studied in 9 patients with a history of bladder malignancies. A single dose of 250 mg. 5-fluorouracil was given orally and the renal clearance of active 5-fluorouracil was approximately 40 ml. per minute. The maximum serum (1,100 ng./ml. serum) and urinary concentrations (49,000 ng./ml. urine) of 5-fluorouracil occurred 20 and 40 minutes after administration, respectively. The urinary concentration per se is highly cytotoxic, whereas the short-lasting serum concentration previously has been proved to be without general cytotoxic effects even after continuous use of the drug for years. Although high concentrations of 5-fluorouracil are noted in the urine the antitumor effects of this treatment must be investigated further.
对9例有膀胱恶性肿瘤病史的患者进行了5-氟尿嘧啶的药代动力学研究。口服单剂量250mg 5-氟尿嘧啶,活性5-氟尿嘧啶的肾清除率约为每分钟40ml。5-氟尿嘧啶的血清最高浓度(血清1100ng/ml)和尿液最高浓度(尿液49000ng/ml)分别在给药后20分钟和40分钟出现。尿液中的浓度本身具有高度细胞毒性,而先前已证明即使连续使用该药物数年,短暂的血清浓度也无一般细胞毒性作用。尽管尿液中5-氟尿嘧啶浓度较高,但这种治疗的抗肿瘤效果仍需进一步研究。